Pharma Launch Secrets
Content, GPT, MLR, and Medical Affairs: How to Make Medical Operations Future-Ready and Lead with Trust, Scientific Evidence, and Omnichannel?
Aug 2, 2023
In this episode, Sameer Lal, SVP at Indegene, discusses content repurposing, the future of small launches and R&D productivity, the growth of Medical Affairs, using GPT for MLR review, and the role of MAPS in the industry. They also explore challenges in regulatory compliance, content choke in the medical industry, MLR approved content creation, and share industry insights and advice.
37:18
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- The podcast highlights the importance of repurposing content to engage healthcare professionals and the potential for AI technologies like GPT to speed up MLR review.
- The evolving role of medical affairs in product launches is discussed, emphasizing the need for personalized, omnichannel communication and collaboration with market access teams.
Deep dives
The Importance of Launches in the Pharmaceutical Industry
The podcast discusses the increasing importance of product launches in the pharmaceutical industry. Recent earnings calls have shown a focus on pipeline development and new indications, with companies prioritizing R&D spending. The industry is recognizing that successful launches are crucial for both the industry's future and individual companies. This shift towards more launches and the emergence of new treatment modalities require different skill sets and approaches to customer segments. Additionally, the impact of US-focused initiatives like the Inflation Reduction Act (IRA) is driving the need for greater R&D productivity and multiple indication launches.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
